Showing results (1-10 of 420) with videos related to
Sort By:
Pageof 42
Journal of Cardiovascular Translational Research|February 7, 2023
Attitudes About Artificially Intelligent Interactive Voice Response Systems Using Amazon Alexa in Cardiovascular Clinics: Insights from the VOICE-COVID-19 StudyElie Ganni, Amir Razaghizad, Emily Oulousian, et al.JMIR Research Protocols|November 23, 2023
Authorship Correction: Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled TrialEmily Oulousian, Seok Hoon Chung, Elie Ganni, et al.European Heart Journal. Digital Health|May 22, 2024
Impact of age and comorbid heart failure on the utility of smart voice-assistant devicesPedro Marques, Anahita Emami, Guang Zhang, et al.JMIR Research Protocols|January 31, 2023
Voice-Based Screening for SARS-CoV-2 Exposure in Cardiovascular Clinics (VOICE-COVID-19-II): Protocol for a Randomized Controlled TrialEmily Oulousian, Seok Hoon Chung, Elie Ganni, et al.Current Cardiovascular Risk Reports|June 28, 2021
Feasibility of Incorporating Voice Technology and Virtual Assistants in Cardiovascular Care and Clinical TrialsPishoy Gouda, Elie Ganni, Peter Chung, et al.Journal of Cardiac Failure|May 24, 2023
Voice-assisted Artificial Intelligence-enabled Screening for Severe Acute Respiratory Syndrome Coronavirus 2 Exposure in Cardiovascular Clinics: Primary Results of the VOICE-COVID-19-II Randomized TrialAbhinav Sharma, Pedro Marques, Guang Zhang, et al.European Heart Journal. Digital Health|January 30, 2023
Voice-based screening for SARS-CoV-2 exposure in cardiovascular clinicsAbhinav Sharma, Emily Oulousian, Jiayi Ni, et al.Scientific Reports|April 14, 2019
Flexible electrical aptasensor using dielectrophoretic assembly of graphene oxide and its subsequent reduction for cardiac biomarker detectionAbhinav Sharma, Jaesung JangSoft Matter|December 14, 2020
Stochastic resetting of active Brownian particles with Lorentz forceIman Abdoli, Abhinav SharmaCanadian Journal of Diabetes|December 29, 2019
Mechanisms by Which Glucagon-Like-Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors Reduce Cardiovascular Risk in Adults With Type 2 Diabetes MellitusAbhinav Sharma, Subodh VermaPageof 42